Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New CEO of Bill and Melinda Gates foundation named

This article was originally published in Scrip

Executive Summary

Susan Desmond-Hellmann has been named as the next chief executive officer of the Bill & Melinda Gates Foundation – effective from the 1 May 2014. An oncologist by training, Dr Desmond-Hellmann is currently the chancellor of the University of California, San Francisco. Prior to her tenure at UCSF, she was president of product development at Genentech, where she led the development and introduction of two of the first gene-targeted therapies for cancer, Avastin and Herceptin. Dr Desmond-Hellmann also currently sits on the board of directors for proctor and Gamble, and Facebook.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC023844

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel